Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon Feb 15, 2024 6:08pm
96 Views
Post# 35883032

RE:New Press Release - Ceapro Inc. Announces the Mailing of Meeting Materials in Connection With the Special Meeting of Securityholders to Approve Merger With Aeterna Zentaris

RE:New Press Release - Ceapro Inc. Announces the Mailing of Meeting Materials in Connection With the Special Meeting of Securityholders to Approve Merger With Aeterna Zentaris"it has mailed and filed a management information circular dated February 9, 2024 " as of 2 days ago nothing was filled with SEDAR.

Seeing the postponement of 2 weeks, maybe they need a 3rd party to convince shareholders that this is a great deal, LOL. I wonder if they would use the same firm that was calling AEZS shareholders 2 years ago telling (per Yahoo Finance conversation thread) them they should vote in favour of the 25 for 1 share consolidation. Since then, the share price has dropped about 96%.

Should the merger pass, they will be consolidating shares again, 3 or 4 for 1. So in a span of 3 plus years, they could have effectively a 100 for 1 AEZS share consolidation. It's a bit better for us CEAPRO shareholders, we'll see for every 1,000 shares an effective dilution first to 60 shares to AEZS then the new company, then after the 3 or 4 for consolidation they will propose later, you'll get 15 or 20 shares of the new company, for each 1,000 CEAPRO shares you currently have. And BTW, when sharres consolidate, they usually erode in value very quickly.
<< Previous
Bullboard Posts
Next >>